Medable Secures $304M in Series D Funding

Clinical research company Medable has secured $304 million in Series D funding, marking its fourth round since 2020, giving the firm a valuation of just over $2 billion. Dr. Michelle Longmire, CEO and Co-founder, Medable joined Cheddar's Opening Bell to discuss the future of the company.

Jun 15, 2022

More Videos

What Amazon, Apple, Microsoft, Meta, and Alphabet Just Told Investors

Angelo Zino, Senior Vice President and Technology Equity Research Analyst at CFRA, breaks down Big Tech earnings, AI spending, and what's next for the Mag 7.

How Phantom Space Plans to Disrupt the Commercial Space Race

Jim Cantrell, Co-Founder and CEO of Phantom Space, explains how the company is working to make rocket launches faster, cheaper, and more scalable.

Meta and Microsoft Just Sent a Big AI Message to Investors

Big Tech is pouring billions into AI. Ray Wang, CEO of Constellation Research, explains what Meta and Microsoft's earnings reveal about those investments.

Can NYC Finally Cool Its Subway?

Why is the NYC subway platform so hot? One rider built his own sensor network to find out. We explore the geothermal fix the MTA is piloting right now.

Boeing's Big Test: Earnings, Deliveries, and the Road Ahead

Morningstar equity analyst Nicolas Owens explains Boeing's latest earnings, deliveries, rising fuel costs, and what they mean for airlines and investors.

Inside Five Star Franchising's Plan to Help the Next Generation of Business Owners

Five Star Franchising CEO Scott Abbott explains why Millennials and Gen Z are embracing franchise ownership and what it means for the future of work.

Businesses Older Than America: 250+ Year Old Companies Still Going Strong

These three American businesses existed before the country itself, and they're still thriving!

The World Cup Isn't Just a Tournament, It's a $41 Billion Business

The 2026 FIFA World Cup is more than just a tournament. With over 6.5 million fans expected to attend, it's become one of the world's largest economic events.